Doses and concentrations
Units, dose volumes, weight-based dosing, strength, and amount of substance.
FREE FORMULAS + PRACTICE
A two-page calculation companion for NAPLEX study, with 24 selected formula groups and the assumptions that make them useful.
Free, with no account required. The revised two-page guide replaces our original one-page sheet.
INSIDE YOUR DOWNLOAD
All 24 formula groups, symbol definitions, abbreviations, and brief use notes are included in the PDF. Keep a copy for study or print both pages.
Units, dose volumes, weight-based dosing, strength, and amount of substance.
Dilution, blending, electrolytes, pump and gravity rates, and ideal osmolarity.
Body measurements, kidney-function estimates, and pharmacokinetics.
Parenteral energy, nitrogen, and interpreting treatment effects.
PUT IT TO WORK
Practice dose volumes, concentrations, dilution, blending, infusion rates, electrolytes, body surface area, half-life, nutrition and number needed to treat. Each answer includes the working and one useful reminder.
Start free calculation practiceSOURCES AND SCOPE
Elementary relationships are checked by dimensional analysis. The references below provide definitions, historical equations and clinical limitations; they do not each support every formula. Definitions and explanations are included beside each formula in the PDF.
Units of Mass. Unit background, not drug doses or pharmaceutical percentage definitions.
Common Units of Volume. Unit background; dilution and rate equations are derived from stated definitions.
Mole definition and specified elementary entities. Does not prescribe electrolyte doses or infusion safety.
BMI as a measure; BMI for screening. BMI is not an automatic dosing weight.
Issues of Concern; reference 4 (Mosteller 1987). The original Mosteller article was not freshly read; the standard square-root grouping was independently checked.
Dosage and Administration, Step 2: Calculation of creatinine clearance. The label specifies actual body weight for TIKOSYN. This does not establish a universal weight convention for other medicines.
Fundamental pharmacokinetic principles; half-life, Equation 5. First-order decay is a mathematical model; drug-specific or multicompartment parameters are not interchangeable.
Loading Dose; Maintenance Dose; Equations 1–3; acute kidney injury discussion. Simplified model relationships do not select a clinical drug dose.
11 Description. This energy value is specific to the named lipid product.
4.1 Proteins; 4.2 Carbohydrates; 4.3 Lipids. The text prints “4 kal/g” for amino acid energy, an apparent unit typography error in calorie context. It is a clinical overview, not an exact label for every amino acid product; actual nitrogen content may differ.
Treatment effect size; ARR, RR, RRR and NNT worked example. Positive whole-person rounding follows the guide convention; confidence intervals require separate methods.
Original educational material. Pharmaste is not affiliated with or endorsed by NABP. Follow question-specific assumptions and current product labeling.